Brian Lestini
President, Oncology @ Biohaven
About
Physician-scientist and pharmaceutical industry leader with nearly 15 years of experience in all aspects of oncology drug development, from early-stage through commercialization. Led the development and first global approvals of OPDIVO (nivolumab, anti-PD1) in previously treated metastatic non-small lung cancer, and OPDUALAG (relatlimab, anti-LAG3) in metastatic melanoma. Strong background and expertise in translational/precision medicine and data-driven drug development. An authentic leader with extensive experience building high-performing teams. A particular passion is professional development and mentorship of rising talent.
United States
New York City Metropolitan Area
Biotechnology
Biomarkers, Biotechnology, CTMS, Clinical Development, Clinical Research, Clinical Trials, Drug Development, Drug Discovery, GCP, Lifesciences, Oncology, Pharmaceutical Industry, Translational Medicine, Medical Affairs, Therapeutic Areas, Life Sciences
Experience

Board Member
NJ League of Conservation Voters

Chief Executive Officer
Pyramid Biosciences
Acquired by Biohaven.

Chief Medical Officer
Pyramid Biosciences
Brian Lestini's Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles

Find Emails
Access verified email addresses for your target contacts.
657M+ emails

Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers

More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.





